Cover Image
Market Research Report

Latin America, Middle East & Africa Pneumonia Vaccines Market (2019-2025)

Published by KBV Research Product code 888290
Published Content info 102 Pages
Delivery time: 1-2 business days
Price
Back to Top
Latin America, Middle East & Africa Pneumonia Vaccines Market (2019-2025)
Published: June 30, 2019 Content info: 102 Pages
Description

The Latin America, Middle East and Africa Pneumonia Vaccines Market would witness market growth of 10.1% CAGR during the forecast period (2019-2025).

Pneumonia is a disease that causes lung contamination occurring in one or both the lungs caused by bacterial organisms, viruses, or fungi; bacterial pneumonia is the most common in adults. Pneumonia results in irritation around the 'sacs', also known as alveoli of the lungs, which causes the alveoli to fill with pus, resulting in breathing issues. PCV13 protects against the 13 kinds of pneumococcal bacteria which cause the most severe illness among children and adults. It is suggested for routine use among children that are 5 years or younger and adults 65 years of age and older. It is also suggested to help prevent pneumococcal disease in individuals through 64 years of age with medical conditions that place them at increased risk for pneumococcal disease. Development of protein-based combination pneumococcal vaccines is expected to offer lucrative opportunities for the expansion of this market during the forecast period.

Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. And MERCK & CO., Inc.

Scope of the Study

Market Segmentation:

By Vaccine Type

  • Pneumococcal conjugate vaccine (PCV)
  • Pneumococcal polysaccharide vaccine (PPSV/PPV)

By Product Type

  • Prevnar 13
  • Synflorix
  • Pneumovax23

By Sector

  • Public sector
  • Private sector

By Distribution Channel

  • Distribution partner companies
  • Non-governmental Organizations (NGO)
  • Government Authorities

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Glaxosmithkline Plc. (GSK)
  • LG Corporation
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • Poonawalla Investments & Industries Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • SK Holdings Co., Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Merck & Co., Inc.
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Pneumonia Vaccines Market, by Vaccine Type
    • 1.4.2 LAMEA Pneumonia Vaccines Market, by Product Type
    • 1.4.3 LAMEA Pneumonia Vaccines Market, by Sector
    • 1.4.4 LAMEA Pneumonia Vaccines Market, by Distribution Channel
    • 1.4.5 LAMEA Pneumonia Vaccines Market, by Region
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Pneumonia Vaccines Market by Vaccine Type

  • 3.1 LAMEA Pneumococcal Conjugate Vaccine (PCV) Market by Region
  • 3.2 LAMEA Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region

Chapter 4. LAMEA Pneumonia Vaccines Market by Product Type

  • 4.1 LAMEA Prevnar 13 Market by Region
  • 4.2 LAMEA Synflorix Market by Region
  • 4.3 LAMEA Pneumovax 23 Market by Region

Chapter 5. LAMEA Pneumonia Vaccines Market by Sector

  • 5.1 LAMEA Private sector Market by Region
  • 5.2 LAMEA Public sector Market by Region

Chapter 6. LAMEA Pneumonia Vaccines Market by Distribution Channel

  • 6.1 LAMEA Distribution Partner Companies Market by Region
  • 6.2 LAMEA Non-Governmental Organizations (NGO) Market by Region
  • 6.3 LAMEA Government Authorities Market by Region

Chapter 7. LAMEA Pneumonia Vaccines Market by Region

  • 7.1 Brazil Pneumonia Vaccines Market
    • 7.1.1 Brazil Pneumonia Vaccines Market by Vaccine Type
    • 7.1.2 Brazil Pneumonia Vaccines Market by Product Type
    • 7.1.3 Brazil Pneumonia Vaccines Market by Sector
    • 7.1.4 Brazil Pneumonia Vaccines Market by Distribution Channel
  • 7.2 Argentina Pneumonia Vaccines Market
    • 7.2.1 Argentina Pneumonia Vaccines Market by Vaccine Type
    • 7.2.2 Argentina Pneumonia Vaccines Market by Product Type
    • 7.2.3 Argentina Pneumonia Vaccines Market by Sector
    • 7.2.4 Argentina Pneumonia Vaccines Market by Distribution Channel
  • 7.3 UAE Pneumonia Vaccines Market
    • 7.3.1 UAE Pneumonia Vaccines Market by Vaccine Type
    • 7.3.2 UAE Pneumonia Vaccines Market by Product Type
    • 7.3.3 UAE Pneumonia Vaccines Market by Sector
    • 7.3.4 UAE Pneumonia Vaccines Market by Distribution Channel
  • 7.4 Saudi Arabia Pneumonia Vaccines Market
    • 7.4.1 Saudi Arabia Pneumonia Vaccines Market by Vaccine Type
    • 7.4.2 Saudi Arabia Pneumonia Vaccines Market by Product Type
    • 7.4.3 Saudi Arabia Pneumonia Vaccines Market by Sector
    • 7.4.4 Saudi Arabia Pneumonia Vaccines Market by Distribution Channel
  • 7.5 South Africa Pneumonia Vaccines Market
    • 7.5.1 South Africa Pneumonia Vaccines Market by Vaccine Type
    • 7.5.2 South Africa Pneumonia Vaccines Market by Product Type
    • 7.5.3 South Africa Pneumonia Vaccines Market by Sector
    • 7.5.4 South Africa Pneumonia Vaccines Market by Distribution Channel
  • 7.6 Nigeria Pneumonia Vaccines Market
    • 7.6.1 Nigeria Pneumonia Vaccines Market by Vaccine Type
    • 7.6.2 Nigeria Pneumonia Vaccines Market by Product Type
    • 7.6.3 Nigeria Pneumonia Vaccines Market by Sector
    • 7.6.4 Nigeria Pneumonia Vaccines Market by Distribution Channel
  • 7.7 Rest of LAMEA Pneumonia Vaccines Market
    • 7.7.1 Rest of LAMEA Pneumonia Vaccines Market by Vaccine Type
    • 7.7.2 Rest of LAMEA Pneumonia Vaccines Market by Product Type
    • 7.7.3 Rest of LAMEA Pneumonia Vaccines Market by Sector
    • 7.7.4 Rest of LAMEA Pneumonia Vaccines Market by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 GLAXOSMITHKLINE PLC (GSK)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.1 Recent strategies and developments:
      • 8.1.1.1 Collaboration, partnerships and agreements:
      • 8.1.1.2 Expansion:
    • 8.1.2 SWOT Analysis
  • 8.2 LG Corporation (LG Chemicals Ltd.)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Panacea Biotec Limited
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Collaboration, partnerships and agreements:
    • 8.3.6 SWOT Analysis
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Collaboration, partnerships and agreements:
      • 8.4.5.2 Product launch:
    • 8.4.6 SWOT Analysis
  • 8.5 PnuVax Incorporated
    • 8.5.1 Company Overview
  • 8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
    • 8.6.1 Company Overview
  • 8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
    • 8.7.1 Company Overview
  • 8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
    • 8.8.1 Company overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expenses
  • 8.9 Walvax Biotechnology Co., Ltd.
    • 8.9.1 Company Overview
    • 8.9.2 Recent strategies and developments:
      • 8.9.2.1 Product launch:
  • 8.1 Merck & Co., Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Collaboration, partnerships and agreements:
      • 8.10.5.2 Product launch:
    • 8.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 2 LAMEA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 3 LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 4 LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 5 LAMEA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 6 LAMEA PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 7 LAMEA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 8 LAMEA PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 9 LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 10 LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 11 LAMEA PREVNAR 13 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 12 LAMEA PREVNAR 13 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 13 LAMEA SYNFLORIX MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 14 LAMEA SYNFLORIX MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 15 LAMEA PNEUMOVAX 23 MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 16 LAMEA PNEUMOVAX 23 MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 17 LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 18 LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 19 LAMEA PRIVATE SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 20 LAMEA PRIVATE SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 21 LAMEA PUBLIC SECTOR MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 22 LAMEA PUBLIC SECTOR MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 23 LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 24 LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 25 LAMEA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 26 LAMEA DISTRIBUTION PARTNER COMPANIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 27 LAMEA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 28 LAMEA NON-GOVERNMENTAL ORGANIZATIONS (NGO) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 29 LAMEA GOVERNMENT AUTHORITIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 30 LAMEA GOVERNMENT AUTHORITIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 31 LAMEA PNEUMONIA VACCINES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 32 LAMEA PNEUMONIA VACCINES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 33 BRAZIL PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 34 BRAZIL PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 35 BRAZIL PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 36 BRAZIL PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 37 BRAZIL PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 38 BRAZIL PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 39 BRAZIL PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 40 BRAZIL PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 41 BRAZIL PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 42 BRAZIL PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 43 ARGENTINA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 44 ARGENTINA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 45 ARGENTINA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 46 ARGENTINA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 47 ARGENTINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 48 ARGENTINA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 49 ARGENTINA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 50 ARGENTINA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 51 ARGENTINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 52 ARGENTINA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 53 UAE PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 54 UAE PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 55 UAE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 56 UAE PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 57 UAE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 58 UAE PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 59 UAE PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 60 UAE PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 61 UAE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 62 UAE PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 63 SAUDI ARABIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 64 SAUDI ARABIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 65 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 66 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 67 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 68 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 69 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 70 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 71 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 72 SAUDI ARABIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 73 SOUTH AFRICA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 74 SOUTH AFRICA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 75 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 76 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 77 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 78 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 79 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 80 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 81 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 82 SOUTH AFRICA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 83 NIGERIA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 84 NIGERIA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 85 NIGERIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 86 NIGERIA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 87 NIGERIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 88 NIGERIA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 89 NIGERIA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 90 NIGERIA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 91 NIGERIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 92 NIGERIA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 93 REST OF LAMEA PNEUMONIA VACCINES MARKET, 2015 - 2018, USD MILLION
  • TABLE 94 REST OF LAMEA PNEUMONIA VACCINES MARKET, 2019 - 2025, USD MILLION
  • TABLE 95 REST OF LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2015 - 2018, USD MILLION
  • TABLE 96 REST OF LAMEA PNEUMONIA VACCINES MARKET BY VACCINE TYPE, 2019 - 2025, USD MILLION
  • TABLE 97 REST OF LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2015 - 2018, USD MILLION
  • TABLE 98 REST OF LAMEA PNEUMONIA VACCINES MARKET BY PRODUCT TYPE, 2019 - 2025, USD MILLION
  • TABLE 99 REST OF LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2015 - 2018, USD MILLION
  • TABLE 100 REST OF LAMEA PNEUMONIA VACCINES MARKET BY SECTOR, 2019 - 2025, USD MILLION
  • TABLE 101 REST OF LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 102 REST OF LAMEA PNEUMONIA VACCINES MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 103 KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 104 KEY INFORMATION - LG CORPORATION
  • TABLE 105 KEY INFORMATION - PANACEA BIOTEC LIMITED
  • TABLE 106 KEY INFORMATION - PFIZER, INC.
  • TABLE 107 KEY INFORMATION - PNUVAX INCORPORATED
  • TABLE 108 KEY INFORMATION - POONAWALLA INVESTMENTS & INDUSTRIES PVT. LTD.
  • TABLE 109 KEY INFORMATION - SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
  • TABLE 110 KEY INFORMATION - SK HOLDINGS CO., LTD.
  • TABLE 111 KEY INFORMATION - WALVAX BIOTECHNOLOGY CO., LTD.
  • TABLE 112 KEY INFORMATION - MERCK & CO., INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
Back to Top